Carl G F, Smith D B
Epilepsia. 1983 Aug;24(4):494-501. doi: 10.1111/j.1528-1157.1983.tb04920.x.
The interactions between folate and phenytoin were studied in the rat using a model in which constant, nontoxic, and continuously protective levels of phenytoin were maintained. After 10 days of treatment with phenytoin, liver folate concentration was decreased while brain, plasma, and adrenal folate concentrations remained unaffected. Oral folate supplementation (20 mg/kg) increased folate concentrations in all tissues examined in phenytoin-treated animals, but had no effect on phenytoin levels. Folate supplementation did, however, increase the recovery time after maximal electroshock seizures in phenytoin-treated rats, but did not influence phenytoin's ability to protect against tonic hindlimb extension. Oral folate supplementation in animals not treated with phenytoin also significantly increased folate concentrations in all tissues examined except brain.
利用一种能维持苯妥英钠恒定、无毒且持续保护水平的模型,在大鼠中研究了叶酸与苯妥英钠之间的相互作用。在用苯妥英钠治疗10天后,肝脏叶酸浓度降低,而脑、血浆和肾上腺叶酸浓度未受影响。口服补充叶酸(20毫克/千克)可提高苯妥英钠治疗动物所有检测组织中的叶酸浓度,但对苯妥英钠水平无影响。然而,补充叶酸确实增加了苯妥英钠治疗大鼠最大电休克惊厥后的恢复时间,但不影响苯妥英钠预防强直性后肢伸展的能力。在未用苯妥英钠治疗的动物中口服补充叶酸也显著提高了所有检测组织(脑除外)中的叶酸浓度。